Transcripts Compass Therapeutics, Inc. OTC Markets

Actions

Temps réel estimé Cboe BZX 16:37:18 23/09/2026			Varia. 5j.	Varia. 1 janv.
1,155 ^USD	-67,46%		+32,67%	-

22/09	Compass Therapeutics affirme que la FDA recommande un nouvel essai sur le tovecimig dans le cancer des voies biliaires ; l’action recule	MT
22/09	Compass Therapeutics, Inc. fournit un point réglementaire sur le tovecimig dans le cancer des voies biliaires après les retours de la FDA	CI

09/06	Transcript : Compass Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 08:00 AM
27/04	Transcript : Compass Therapeutics, Inc. - Special Call
14/01	Transcript : Compass Therapeutics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 07:30 AM
04/12	Transcript : Compass Therapeutics, Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-04-2025 10:00 AM
04/12	Transcript : Compass Therapeutics, Inc. Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-02-2025 08:00 AM
10/09/25	Transcript : Compass Therapeutics, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 05:35 PM
11/08/25	Transcript : Compass Therapeutics, Inc. - Special Call
01/04/25	Transcript : Compass Therapeutics, Inc. - Special Call
23/01/23	Transcript : Compass Therapeutics, Inc. - Special Call